The efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotibib alone in the treatment of non-small cell lung cancer: A systematic review and meta-analysis

Abstract Objective To compare combination treatment with bevacizumab and erlotinib to bevacizumab or erlotinib monotherapy in NSCLC treatment. Methods Randomized controlled trials (RCTs), published in Pubmed, Web of Science, and Embase were systematically reviewed to evaluate the survival benefits a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2015
Hauptverfasser:	Wang, Liping, Fu, Pengcheng, Zhang, Guilin, Wu, Zhengqing, Zhang, Hua, Qin, Ling, Liu, Hailong, Huang, Chaogang
Format:	Artikel
Sprache:	eng
Schlagworte:	Bevacizumab Erlotinib Internal Medicine Medical Education Meta-analysis Non-small cell lung cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!